Auditory Analysis Speech Technology Adopted for Early Detection Study of EverythingALS

featured image

Phoenix – (business wire) — Aural Analytics, Inc., a leader in clinical-grade speech analytics, today announced that it has been selected for the EverythingALS Early Detection Study for the next 12 months. This study focuses on using Aural Analytics’ Speech Vitals technology to reliably capture everyday audio features in your home.

Aural Analytics CEO Judy Smythe said: “This collaboration with EverythingALS can transform the way we study disease using digital voice technology to advance the medical field and especially her ALS community.”

EverythingALS will use Aural Analytics’ Speech Vitals service to investigate whether data collected by specific digital audio technologies can indicate changes in early ALS. This study explores the potential of data obtained from voice analysis, sole sensors, and handheld spirometers, integrated with key demographic and existing clinical data. The data collected will be used to stage disease for the purpose of future research to meet the unmet needs of ALS patients by developing a new “digital ALSFRS-R” scale to improve ALSFRS-R. Applied to characterize and track disease progression in ALS. scale.

ALS is the most common adult-onset motor neuron disease. It is estimated that over 30,000 people in the United States and 450,000 people worldwide live with the condition. Globally, studies show that the ALS treatment market will reach $885.5 million by 2026, growing at an annual rate of 5.8% from 2020 to 2026 due to rising cases and increased research and development of treatments. The national economic burden of ALS is estimated at up to $472 million, more than any other neurological disease.

Aural Analytics is the leader in the speech analytics market and supports various ALS projects. He has supported 9 studies on ALS treatment and completed over 27,000 ALS speech sessions for patients. This new research has the potential to advance the ALS detection process. This includes all-new data streams and tasks that help identify measures of disease progression while giving patients the option to monitor their symptoms without being physically in the clinic. increase.

Speech Vitals is an easy-to-use, accurate, clinical-grade technology platform validated by large healthcare systems and pharmaceutical companies. Aural Analytics strives to create patient-centric technology by making data easily accessible and retrieving through mobile measurements.

About Oral Analytics Inc.

Aural Analytics is a leading speech neuroscience company, harnessing the clinical utility of speech for all ages worldwide. The company’s suite of applications and embeddable SDKs and APIs are available in 25 languages ​​on Android, iOS and web and are easy to use, secure, robust, clinically relevant, interpretable and validated and reflects neurological and respiratory health. user. For more information, visit or follow Aural Analytics. twitterLinkedIn, Medium, and Facebook.

About EverythingALS

EverythingALS is a patient-centric, non-profit organization focused on technology to support care-to-treatment efforts for ALS patients by providing an open data platform for direct engagement with patients, caregivers, researchers and pharmaceutical companies. Bring innovation and data science. .

For more information, please visit